Blacklegged ticks (Ixodes scapularis) transmit several tick-borne diseases (TBDs). Warming temperatures and land use changes are anticipated to aid blacklegged tick range expansion and increase the risk of human infection with tick-borne pathogens. Along with Borrelia burgdorferi (bacterium that causes Lyme disease), blacklegged ticks can transmit other pathogens including Anaplasma phagocytophilum (anaplasmosis), Babesia microti and other Babesia spp. (babesiosis), and Powassan virus (Powassan virus infection). On July 1, 2023, the Ontario Ministry of Health designated anaplasmosis, babesiosis and Powassan virus as Diseases of Public Health Significance (DoPHS), in addition to Lyme disease which has been a reportable disease in Ontario since 1991.
Due to the establishment of blacklegged tick populations, all of Toronto is considered at risk for these tick-borne diseases of public health significance. However, the overall risk of acquiring these diseases remains low.
This page contains information relevant to all tick-borne diseases of public health significance (TBDoPHS).
For disease specific information, see Lyme Disease Information for Health Professionals, Anaplasmosis Information for Health Professionals, Babesiosis Information for Health Professionals and Powassan Virus Infection Information for Health Professionals.
For the most up-to-date trends in human cases for TBDoPHS see PHO’s Ontario Vector-Borne Disease Tool. This tool is updated weekly for all human cases.
For information about TPH’s blacklegged tick surveillance program and the latest tick dragging results, visit TPH’s Blacklegged Tick Surveillance.
TBDoPHS can have similar and non-specific signs and symptoms, which may include:
The combination of symptoms varies greatly from person to person. Refer to the individual TBDoPHS pages for specific signs and symptoms.
The following summary table from Public Health Ontario may assist in distinguishing between TBDoPHS symptoms:
| Criteria | Lyme Disease | Anaplasmosis | Babesiosis | Powassan virus |
|---|---|---|---|---|
| Tick Bite Risk | ≥ 24-36 hours | ≥ 12-24 hours | ≥ 36-48 hours* | ≤ 15 minutes |
| Incubation | 3 to 30 days | 5 to 21 days | 1 to 3 weeks (tick bite) or
1 to 24 weeks (transfusion) |
1 to 5 weeks |
| Skin Lesions | Erythema migrans (70%) | Maculopapular (≤10%) | Petechiae (rare, if severe) | Morbiliform (rare) |
| Other Differential Symptoms | Arthralgia, headache, lymphadenopathy, subacute or late manifestations | Arthralgia, headache, occasionally multi-organ failure | High fever, dark urine, severe if low immunity or low splenic function | Encephalitis after short prodrome (1-3 days) and 50% have sequelae |
| Routine Blood Work | Usually normal in early localized cases | Leukopenia (>45%), thrombocytopenia (>70%),
high transaminases (>50%) |
Hemolytic anemia (>90%), thrombocytopenia (>60%),
high transaminases (>70%) |
Usually normal (<15% thrombocytopenia) |
Note:*May be at least 24 hours (MOH)
Sources:Sanchez E, Vannier E, Wormser GP, Hu LT. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis. JAMA. 2016;315(16):1767-1777. Available from: https://doi.org/10.1001/jama.2016.2884Dumic I, Jevtic D, Veselinovic M, Norstrom CW, Jovanovic M, Mogulla V, et al. Human Granulocytic Anaplasmosis—A Systematic Review of Published Cases. Microorganisms. 2022;10(7):1433. Available from: https://doi.org/10.3390/microorganisms10071433White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL. Human Babesiosis in New York State. Review of 139 Hospitalized Cases and Analysis of Prognostic Factors. Arch Intern Med. 1998;158(19):2149-2154. Available from: https://doi.org/10.1001/archinte.158.19.2149Piantadosi A, Rubin DB, McQuillen DP, Hsu L, Leder PA, Ashbaugh CD et al. Emerging Cases of Powassan Virus Encephalitis in New England: Clinical Presentation, Imaging, and Review of the Literature. Clin Infect Dis. 2016;62(6):707-713. Available from: https://doi.org/10.1093/cid/civ1005
Knowledge of a patient’s exposure to blacklegged ticks is an important parameter for tick-borne disease diagnosis.
Diagnosis, testing and treatment varies by TBDoPHS. Testing is generally not indicated for asymptomatic patients. For specific recommendations, see:
The following summary table from Public Health Ontario may assist in distinguishing between testing and treatment options:
| Criteria | Lyme Disease | Anaplasmosis | Babesiosis | Powassan virus |
|---|---|---|---|---|
| Routine Core Lab Tests | Usually normal in early localized cases | Leukopenia (>45%), thrombocytopenia (>70%),
high transaminases (>50%) |
Hemolytic anemia (>90%), thrombocytopenia (>60%),
high transaminases (>70%) |
Usually normal (<15% thrombocytopenia) |
| Main Diagnostic Tests | Early localized: Clinical
Other stages: Serology (paired) |
Acute illness: PCR
Subacute illness: Serology (paired) |
Acute, prolonged, or relapsing illness: Smears +/- PCR | Prodrome: PCR
Encephalitis stage: Serology (paired) |
| Main Treatment Options | Doxycycline, amoxicillin, cefuroxime, or ceftriaxone | Doxycycline | Atovaquone plus azithromycin, or clindamycin plus quinine | None (supportive) |
Source: Rodino KG, Theel ES, Pritt BS. Tick-Borne Diseases in the United States. Clin Chem. 2020;66(4):537-548. Available from: https://doi.org/10.1093/clinchem/hvaa040
Prevention of tick bites will reduce the risk of all TBDoPHS. Visit Toronto Public Health’s Environmental Health Lyme disease prevention page for information and how to prevent tick bites.
An electronic tick identification platform eTick, is available in Ontario, where anyone can submit a photo of a tick and receive species identification results within 48 hours. This free publicly available tick identification platform can be used for ticks found on a person, pet or in the environment.
There is no longer an added benefit to continue passive tick surveillance because all of Toronto is considered an estimated risk area. Toronto Public Health continues to perform selective active surveillance activities. It is not recommended to submit ticks to Public Health Ontario (PHO) for clinical purposes.
If you wish to submit a tick to the PHO labs, please visit their website for more information.
Report all suspect or confirmed cases of Lyme Disease, Anaplasmosis, Babesiosis or Powassan Virus to TPH at 416-392-7411 during business hours (8:30 am to 4:30 pm, Monday to Friday) or 311 after hours.